Drug-resistant Acinetobacter baumannii is a growing global health threat and high priority pathogen needing new antibiotics, according to World Health Organization China NMPA approval based on ...
Each year, more than 670,000 people in Europe fall ill due to pathogenic bacteria that exhibit antibiotic resistance, and 33,000 die of the diseases they cause. Especially feared are pathogens that ...
Hospital-acquired infections (HAIs) are often particularly difficult to treat because the pathogens have developed resistance to common antibiotics. The bacterium Acinetobacter baumannii is ...
Zai Lab Limited, an innovative, research-based, commercial-stage biopharmaceutical company, and Innoviva Specialty Therapeutics announced that China’s National Medical Products Administration (NMPA) ...
JERUSALEM, Israel, June 3, 2026 -- Omnix Medical, a biopharmaceutical company developing next-generation anti-infectives for severe multidrug-resistant infections, announced today that the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results